Insider Transactions in Q2 2024 at Athira Pharma, Inc. (ATHA)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2024
|
Kelly A Romano |
BUY
Open market or private purchase
|
Direct |
27,400
+25.34%
|
$54,800
$2.42 P/Share
|
|
Jun 21
2024
|
Kelly A Romano |
BUY
Open market or private purchase
|
Direct |
15,000
+21.96%
|
$30,000
$2.26 P/Share
|
|
May 20
2024
|
Andrew Gengos CFO and Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+9.63%
|
$10,000
$1.34 P/Share
|
|
May 20
2024
|
Mark Worthington General Counsel and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+18.36%
|
$10,000
$1.34 P/Share
|
|
May 20
2024
|
Kevin Church CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,953
+5.49%
|
$4,953
$1.34 P/Share
|